Dashboard
Manage Tickers

OCUL


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

chardan-capital-maintains-buy-on-ocular-therapeutix-maintains-21-price-target
Chardan Capital Maintains Buy on Ocular Th...
11/05/2025 12:42:34

Chardan Capital analyst Daniil Gataulin maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $21 price target.

ocular-therapeutix-q3-eps-038-misses-037-estimate-sales-14544m-miss-14627m-estimate
Ocular Therapeutix Q3 EPS $(0.38) Misses $...
11/04/2025 12:06:26

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.38) per share which missed the analyst consensus estimate of ...

earnings-scheduled-for-november-4-2025
Earnings Scheduled For November 4, 2025
11/04/2025 11:12:08

td-cowen-maintains-buy-on-ocular-therapeutix-raises-price-target-to-20
TD Cowen Maintains Buy on Ocular Therapeut...
10/30/2025 20:14:02

TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $14 to...

eli-lilly-to-rally-more-than-12-here-are-10-top-analyst-forecasts-for-wednesday
Eli Lilly To Rally More Than 12%? Here Are...
10/08/2025 14:04:25

hc-wainwright--co-maintains-buy-on-ocular-therapeutix-raises-price-target-to-19
HC Wainwright & Co. Maintains Buy on Ocula...
10/08/2025 10:16:00

HC Wainwright & Co. analyst Yi Chen maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target fr...

piper-sandler-maintains-overweight-on-ocular-therapeutix-raises-price-target-to-31
Piper Sandler Maintains Overweight on Ocul...
10/03/2025 15:11:38

Piper Sandler analyst Biren Amin maintains Ocular Therapeutix (NASDAQ:OCUL) with a Overweight and raises the price target fr...

baird-maintains-outperform-on-ocular-therapeutix-raises-price-target-to-24
Baird Maintains Outperform on Ocular Thera...
10/03/2025 11:43:22

Baird analyst Colleen Kusy maintains Ocular Therapeutix (NASDAQ:OCUL) with a Outperform and raises the price target from $17...

chardan-capital-maintains-buy-on-ocular-therapeutix-maintains-21-price-target
Chardan Capital Maintains Buy on Ocular Th...
10/02/2025 12:30:05

Chardan Capital analyst Daniil Gataulin maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and maintains $21 price target.

needham-maintains-buy-on-ocular-therapeutix-raises-price-target-to-20
Needham Maintains Buy on Ocular Therapeuti...
10/01/2025 18:24:50

Needham analyst Serge Belanger maintains Ocular Therapeutix (NASDAQ:OCUL) with a Buy and raises the price target from $15 to...

expert-outlook-ocular-therapeutix-through-the-eyes-of-4-analysts
Expert Outlook: Ocular Therapeutix Through...
10/01/2025 14:02:23

jmp-securities-maintains-market-outperform-on-ocular-therapeutix-raises-price-target-to-29
JMP Securities Maintains Market Outperform...
10/01/2025 12:46:21

JMP Securities analyst Jonathan Wolleben maintains Ocular Therapeutix (NASDAQ:OCUL) with a Market Outperform and raises the ...

ocular-therapeutix-raises-475m-in-stock-offering-of-379m-shares-at-1253share-to-fund-eye-disease-drug-trials
Ocular Therapeutix Raises $475M In Stock O...
09/30/2025 11:11:38

Ocular Therapeutix, Inc. (NASDAQ:OCUL) ("Ocular", the "Company"), an integrated biopharmaceutical company commi...

ocular-therapeutix-showcases-progress-on-new-eye-drug-that-could-change-treatment-for-vision-loss
Ocular Therapeutix Showcases Progress On N...
09/30/2025 10:22:48

Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular"))), an integrated biopharmaceutical company committed to redefining the...

this-broadcom-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-monday
This Broadcom Analyst Begins Coverage On A...
09/15/2025 11:22:08

chardan-capital-initiates-coverage-on-ocular-therapeutix-with-buy-rating-announces-price-target-of-21
Chardan Capital Initiates Coverage On Ocul...
09/15/2025 10:21:31

Chardan Capital analyst Daniil Gataulin initiates coverage on Ocular Therapeutix (NASDAQ:OCUL) with a Buy rating and announc...

ocular-therapeutix-receives-written-agreement-regarding-trial-design-from-fda-under-special-protocol-assessment-for-registrational-trial-of-axpaxli-in-npdr
Ocular Therapeutix Receives Written Agreem...
08/12/2025 11:10:01

scotiabank-maintains-sector-outperform-on-ocular-therapeutix-lowers-price-target-to-20
Scotiabank Maintains Sector Outperform on ...
08/06/2025 16:35:52

Scotiabank analyst Greg Harrison maintains Ocular Therapeutix (NASDAQ:OCUL) with a Sector Outperform and lowers the price ta...

ocular-therapeutix-q2-eps-039-misses-036-estimate-sales-13459m-beat-13253m-estimate
Ocular Therapeutix Q2 EPS $(0.39) Misses $...
08/05/2025 11:02:50

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of ...

Core News & Articles
Earnings Scheduled For August 5, 2025
08/05/2025 08:32:54

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION